Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ISCO | US
0
0%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.06
0.06
0.06
0.06
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
0.0%1 month
303.0%3 months
265.2%6 months
397.8%-
-
-
-
-
166.00
0.41
-
-356.00K
480.26K
480.26K
-
6.39
-74.20
26.60
-185.37
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.01
Range1M
0.03
Range3M
0.04
Rel. volume
0.05
Price X volume
1.98
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
NexImmune Inc. Common Stock | NEXI | Biotechnology | 0.2514 | 350.62K | -23.82% | n/a | 0.00% |
Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0.002 | 253.57K | 0.00% | n/a | 113.12% |
Navidea Biopharmaceuticals Inc | NAVB | Biotechnology | 0.001 | 100.08K | 0.00% | n/a | -38.49% |
U.S. Stem Cell Inc | USRM | Biotechnology | 0.0001 | 64.15K | 0.00% | n/a | -60.68% |
EFTR | EFTR | Biotechnology | 0.0012 | 5.64K | 0.00% | n/a | 2315.36% |
Calithera Biosciences Inc | CALA | Biotechnology | 0.001 | 4.87K | -50.00% | n/a | 8.17% |
OCEAW | OCEAW | Biotechnology | 0.0398 | 0 | 2.58% | n/a | -16.02% |
Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.15 | 0 | 9.52% | n/a | 1.72% |
NKGen Biotech Inc. Warrants | NKGNW | Biotechnology | 0.032 | 0 | 29.03% | n/a | -40.33% |
JSPRW | JSPRW | Biotechnology | 0.21 | 0 | 0.00% | n/a | 2.31% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 166.00 | 0.53 | Expensive |
Ent. to Revenue | 0.41 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | - | 15.55 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 265.19 | 72.80 | Riskier |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 480.26K | 3.66B | Emerging |